BRIONES MEIJIDE, JAVIER FGS
jbriones@santpau.cat
Arguello de Tomas, Miquel FGS
Bober, Anna IR
Caballero Gonzalez, Ana Carolina FGS
Castellet Farrus, Helena IR
De La Riva Buissen, Antonio IR
De Rueda Gamboa, Maria Jessica IR
Escriba Garcia, Laura IR
Esquirol Sanfeliu, Albert FGS
Garcia Cadenas, Irene FGS
Garrido Diaz, Anna FGS
Gonzalez Alvarez, Iria FGS
Gonzalez Alvarez, Nuria FGS
Guardiola Perello, Maria IR
Iniesta Ruiz, Elena IR
Iranzo Ribera, Eva IR
Lopez Moreno, Sonia IR
Lopez Pardo, Jordi FGS
Martino Bofarull, Rodrigo FGS
Miqueleiz Alamos, Sara IR
Montserrat Torres, Rosanna IR
Perez Garcia, Nuria IR
Pujol Fernandez, Paula IR
Rodriguez Fernandez, Diana IR
Rosal Muntadas-Prim, Maria Josefa IR
Poyatos Dorado, Paula IR
Saavedra Gerosa, Silvana Daniela FGS
Samso Zamora, Claudia IR
Sierra Gil, Jordi FGS
Ujaldon Miro, Cristina IR
Victoria Fraj, Sara IR
(JIF 2022)
-Albiol N, Lynton E, Aso O, Moga E, Vidal S, Gomez L, Santiago JA, Triquell M, Roch N, Lazaro E, Gonzalez I, Lopez J, Esquirol A, Sierra J, Martino R, Garcia I. mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect. LEUKEMIA RESEARCH. 2023; 132:107347. DOI:10.1016/j.leukres.2023.107347. PMID:37356281. IF:2,700 (Q3/7D). Document type: Article.
-Arguello M, Albiol N, Jara P, Garcia I, Redondo S, Esquirol A, Novelli S, Saavedra S, Martino R, Nomdedeu J, Sierra J, Mora A, Moreno C. Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center. LEUKEMIA & LYMPHOMA. 2023; 64(10)DOI:10.1080/10428194.2023.2232489. PMID:37452739. IF:2,600 (Q3/7D). Document type: Article.
-Arguello M, Albiol N, Moreno C. Frontline therapy in Chronic Lymphocytic Leukemia. ACTA HAEMATOLOGICA. 2023; DOI:10.1159/000534730. PMID:37899041. IF:2,400 (Q3/8D). Document type: Review.
-Bailén R, Alenda R, Herruzo B, Acosta C, Vallés A, Esquirol A, Fonseca M, Solán L, Sánchez I, Bautista G, Bento L, López O, Pérez A, Torrent A, Zanabili J, Calbacho M, Moreno MÁ, Pascual MJ, Guerra L, Chinea A, García I, López L, Boix F, López JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernández P, Anguita J, Kwon M, Grupo Espanol de Trasplante Hematopoyetico Terapia Celular (GETH Y. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Frontiers in Immunology. 2023; 14:1165759. DOI:10.3389/fimmu.2023.1165759. PMID:37304258. IF:7,300 (Q1/3D). Document type: Article.
-Barba P, Morgades M, Montesinos P, Gonzalez J, Torrent A, Gil C, Bernal T, Tormo M, Mercadal S, Novoa S, Garcia I, de Llano MPQ, Cervera M, Coll R, Bermudez A, Amigo ML, Monsalvo S, Esteve J, Garcia R, Novo A, Rivas JMH, Cladera A, Martinez P, Serrano J, Artola MT, Soria B, Abella E, Vall F, Bergua J, Herrera P, Barrios D, Ribera JM, Spanish GRP. Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols. Hemasphere. 2023; 7(1):e810. DOI:10.1097/HS9.0000000000000810. PMID:36583094. IF:6,600 (Q1/3D). Document type: Letter.
-Baron F, Nagler A, Galimard JE, Sanz J, Versluis J, Forcade E, Chevallier P, Sirvent A, Anthias C, Kuball J, Furst S, Rambaldi A, Sierra J, von dem Borne PA, Gallego MP, Cluzeau T, Robinson S, Raiola AM, Labussière H, Byrne JL, Malfuson JV, Ruggeri A, Mohty M, Ciceri F. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study. BRITISH JOURNAL OF HAEMATOLOGY. 2023; DOI:10.1111/bjh.19130. PMID:37784256. IF:6,500 (Q1/3D). Document type: Article.
-Bastos M, Gutierrez A, Iacoboni G, López L, Reguera JL, Abrisqueta P, Delgado J, Terol MJ, Hernani R, Martínez N, Ortíz V, Bailen R, Gomez I, Caballero A, Sanz J, Guerra L, Luzardo H, Mussetti A, Jiménez A, Sancho JM, Sureda A, Pérez A, Barba P, Kwon M, Martín García A. Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study. Transplantation And Cellular Therapy. 2023; 29(12)DOI:10.1016/j.jtct.2023.08.026. PMID:37659694. IF:3,200 (Q2/5D). Document type: Article.
-Berengua C, Martino R. Quantitative PCR for the Diagnosis of HCMV Pneumonia in HSCT Recipients and Other Immunocompromised Hosts. Hemato. 2023; 4(1)DOI:10.3390/hemato4010008. Document type: Review.
-Berengua C, Miro E, Gutierrez C, Sanchez M, Mulero A, Ramos P, del Cuerpo M, Torrego A, Garcia I, Pajares V, Navarro F, Martino R, Rabella N. Detection of cytomegalovirus in bronchoalveolar lavage fluid from immunocompromised patients with pneumonitis by viral culture and DNA quantification. JOURNAL OF VIROLOGICAL METHODS. 2023; 317:114743. DOI:10.1016/j.jviromet.2023.114743. PMID:37116585. IF:3,100 (Q2/5D). Document type: Article.
-Caballero AC, Escribà L, Pujol P, Escudero E, Ujaldón C, Montserrat R, Sierra J, Alvarez C, Briones J. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion. CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00518-6. PMID:36031661. IF:6,400 (Q1/2D). Document type: Article.
-Coll CF, de la Fe MM, Garcia LP, Vaz CP, Fernando M, Almorox RB, Garcia I, Munoz MC, Ripa TZ, Al JZ, Novoa S, Aguado B, Catarineu AT, Lopez O, Bofarull RM, Kwon M, Campos A, Barrigon DC, Santasusana JMR. Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; 110(6)DOI:10.1111/ejh.13947. PMID:36813736. IF:3,100 (Q3/6D). Document type: Article.
-Cruz D, Rodríguez R, González M, García I, de la Cámara R, Heras I, Buño I, Santos N, Lloveras N, Velarde P, Tuset E, Martínez C, González M, Sanz GF, Ferrá C, Sampol A, Coll R, Pérez JA, López J, Jurado M, Gallardo D, the GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic T. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Frontiers in Immunology. 2023; 14:1066393. DOI:10.3389/fimmu.2023.1066393. PMID:36742309. IF:7,300 (Q1/3D). Document type: Article.
-Del Principe MI, Seidel D, Criscuolo M, Dargenio M, Racil Z, Piedimonte M, Marchesi F, Nadali G, Koehler P, Fracchiolla N, Cattaneo C, Klimko N, Spolzino A, Karapinar DY, Demiraslan H, Duarte RF, Demeter J, Stanzani M, Melillo L, Basilico CM, Cesaro S, Paterno G, Califano C, Delia M, Buzzatti E, Busca A, Cornely OA, Pagano L, Alakel N, Arsenijevi’c VA, Camus V, Falces I, Itzhak L, Kouba M, Martino R, Sedlacek P, Weinbergerova B, FUNGISCOPE Global Emerging F, SEIFEM E. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope. MYCOSES. 2023; 66(1)DOI:10.1111/myc.13524. PMID:36064299. IF:4,900 (Q1/2D). Document type: Article.
-Dickinson MJ, Barba P, Jäger U, Shah NN, Blaise D, Briones J, Shune L, Boissel N, Bondanza A, Mariconti L, Marchal A-L, Quinn DS, Yang J, Price A, Sohoni A, Treanor LM, Orlando EJ, Mataraza J, Davis J, Lu D, Zhu X, Engels B, Moutouh L, Brogdon JL, Moschetta M, Flinn IW. A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development. Cancer Discovery. 2023; 13(9)DOI:10.1158/2159-8290.CD-22-1276. PMID:37249512. IF:28,200 (Q1/1D). Document type: Article.
-Esquirol A, Cadenas IG, Novelli S, Garrido A, Caballero AC, Oñate G, Lopez J, Redondo S, Argüello M, Saavedra S, Moreno C, Briones J, Sierra J, Martino R. Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience. ANNALS OF HEMATOLOGY. 2023; DOI:10.1007/s00277-023-05530-w. PMID:37971549. IF:3,500 (Q2/5D). Document type: Article.
-Fernandez J, Valdivia E, Esquirol A, Portos JM, Rovira M, Suarez M, Diaz C, Uria ML, Ortí G, Ferra C, Mussetti A, Paviglianiti A, Marsal J, Badell I, Lozano M, Gomez D, Azqueta C, Martorell L, Rubio N, Garcia A, Villa J, Carreras E, Querol S. Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience. VOX SANGUINIS. 2023; 118(9)DOI:10.1111/vox.13499. PMID:37533171. IF:2,700 (Q3/7D). Document type: Article.
-García CB, Sierro B, García E, Sanoja L, Muñoz R, Ruiz V, Jimenez MR, Delgado J, Molinos Á, Guijarro B, Carrasco I, Lucena J-M, García J-R, Blázquez C, Reguera JL, González M-F, Reinoso M, Briones J, Pérez JA, Caballero T. Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies. Frontiers in Immunology. 2023; 14:1152498. DOI:10.3389/fimmu.2023.1152498. PMID:37122702. IF:7,300 (Q1/3D). Document type: Article.
-Garcia I, Redondo S, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Onate G, Lopez J, Caballero AC, Miqueleiz S, Arguello M, Briones J, Sierra J, Martino R. Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature. Transplantation And Cellular Therapy. 2023; 29(7):473.e1-473.e6. DOI:10.1016/j.jtct.2023.04.008. PMID:37086849. IF:3,200 (Q2/5D). Document type: Review.
-Kwon M, Iacoboni G, Reguera JL, López L, Morales RH, Ortiz V, Guerreiro M, Caballero AC, Domínguez MLG, Pina JMS, Mussetti A, Sancho JM, Bastos M, Catala E, Delgado J, Henriquez HL, Sanz J, Calbacho M, Bailén R, Carpio C, Ribera JM, Sureda A, Briones J, Hernandez JC, Cebrián NM, Martin JLD, Martín A, Barba P, behalf of GETH T, GELTAMO (Spanish Group of Lymphoma and Autologous Stem Cell T. Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. HAEMATOLOGICA. 2023; 108(1)DOI:10.3324/haematol.2022.280805. PMID:35770532. IF:10,100 (Q1/2D). Document type: Article.
-Martin L, Garcia I, Lopez S, Martinez A, Vilalta N, Plaza M, Moret C, Vinuela A, Brown AA, Panousis NI, Buil A, Dermitzakis ET, Corrales I, Souto JC, Vidal F, Soria JM. Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism. THROMBOSIS AND HAEMOSTASIS. 2023; 123(04)DOI:10.1055/s-0043-1760844. PMID:36696913. IF:6,700 (Q1/2D). Document type: Article.
-Moia R, Dondolin R, De Propris MS, Talotta D, Mouhssine S, Perutelli F, Reda G, Mattiello V, Rigolin GM, Motta M, Olivieri J, Fanin R, Perbellini O, Ferrarini I, Mauro FR, Del Giudice I, Laurenti L, Tomasso A, Gentile M, Frustaci AM, Tedeschi A, Gozzetti A, Stelitano C, Visco C, Moreno C, Forconi F, Marasca R, Coscia M, Rossi D, Foà R, Gaidano G. Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. HEMATOLOGICAL ONCOLOGY. 2023; 41(3)DOI:10.1002/hon.3080. PMID:36190298. IF:3,300 (Q2/5D). Document type: Letter.
-Moreno C, Solman IG, Tam CS, Grigg A, Scarfò L, Kipps TJ, Srinivasan S, Mali RS, Zhou C, Dean JP, Szafer E, Choi M. Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study. Blood Advances. 2023; 7(18)DOI:10.1182/bloodadvances.2023010236. PMID:37315225. IF:7,500 (Q1/2D). Document type: Article.
-Munir T, Moreno C, Owen C, Follows G, Benjamini O, Janssens A, Levin MD, Osterborg A, Robak T, Simkovic M, Stevens D, Voloshin S, Vorobyev V, Yagci M, Ysebaert L, Qi KQ, Qi QY, Parisi L, Srinivasan S, Schuier N, Baeten K, Howes A, Caces DB, Niemann CU, Kater AP. Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(21)DOI:10.1200/JCO.22.02283. PMID:37279408. IF:45,300 (Q1/1D). Document type: Article.
-Muñoz A, Ay C, Grilz E, López S, Font C, Pachón V, Castellón V, Martínez V, Salgado M, Martínez E, Calzas J, Ortega L, Rupérez A, Salas E, Pabinger I, Soria JM. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16)DOI:10.1200/JCO.22.00255. PMID:36730884. IF:45,300 (Q1/1D). Document type: Article.
-Murthy HS, Zhang MJ, Chen K, Ahmed S, Deotare U, Ganguly S, Kansagra A, Michelis FV, Nishihori T, Patnaik MM, Abid MB, Aljurf M, Arai Y, Bacher U, Badar T, Badawy SM, Ballen K, Battiwalla M, Beitinjaneh A, Bejanyan N, Bhatt VR, Brown VI, Martino R, Cahn JY, Castillo P, Cerny J, Chhabra S, Copelan EA, Daly A, Dholaria B, Diaz MA, Freytes CO, Grunwald MR, Hashmi S, Hildebrandt GC, Jamy O, Joseph J, Kanakry CG, Khera N, Krem MM, Kuwatsuka Y, Lazarus HM, Lekakis LJ, Liu H, Modi D, Munshi P, Mussetti A, Palmisiano N, Patel SS, Rizzieri DA, Seo S, Shah MV, Sharma A, Solh MM, Solomon SR, Ulrickson ML, Ustun C, van der Poel MWM, Verdonck LF, Wagner JL, Wang TP, Wirk B, Zeidan AM, Litzow MR, Kebriaei P, Hourigan CS, Weisdorf DJ, Saber W, Kharfan MA. Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis. Blood Advances. 2023; 7(22)DOI:10.1182/bloodadvances.2023011308. PMID:37792849. IF:7,500 (Q1/2D). Document type: Article.
-Mussetti A, Bento L, Bastos M, Sansalvador BR, Albo C, Bailen R, Barba P, Benzaquen A, Briones J, Caballero AC, Campos A, Espanol I, Ferra C, Lopez SG, Sierra P, Guerra LM, Hernani R, Iacoboni G, Ubieto A, Kwon M, Corral LL, Lopez O, Munoz MCM, Martinez N, Gomez JM, Perez L, Ortf G, Ortiz V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yanez L, Varela R, Echechipia IC, Caballero D, Sureda A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01949-x. PMID:36918682. IF:4,800 (Q1/2D). Document type: Article.
-Nunez Y, Garcia A, Falgas A, Serna N, Sanchez L, Garrido A, Sierra J, Gallardo A, Unzueta U, Vazquez E, Villaverde A, Mangues R, Casanova I. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 2023; 15(3):727. DOI:10.3390/pharmaceutics15030727. PMID:36986589. IF:5,400 (Q1/2D). Document type: Article.
-Onate G, Pratcorona M, Garrido A, Artigas A, Bataller A, Tormo M, Arnan M, Vives S, Coll R, Salamero O, Vall F, Sampol A, Garcia A, Cervera M, Avila SG, Bargay J, Ortín X, Nomdedéu JF, Esteve J, Sierra J, Spanish Cooperative Study GRP. Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood Cancer Journal. 2023; 13(1):69. DOI:10.1038/s41408-023-00839-1. PMID:37147301. IF:12,800 (Q1/1D). Document type: Article.
-Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon S-S, Maeda Y, Hosono N, Onozawa M, Kato T, Kim H-J, Hasabou N, Nuthethi R, Tiu R, Levis MJ. Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy. Transplantation And Cellular Therapy. 2023; 29(4):265.e1-265.e10. DOI:10.1016/j.jtct.2022.12.006. PMID:36526260. IF:3,200 (Q2/5D). Document type: Article.
-Piñana JL, Heras I, Aiello TF, García I, Vazquez L, Lopez J, Chorao P, Aroca C, García C, Arroyo I, Soler E, López L, Avendaño A, Arrufat A, Garcia V, Arellano E, Hernández L, González C, Morell J, Hernández JA, Rodriguez P, Mico M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C, Infect Complications Subcomm S. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses-Basel. 2023; 15(10):2066. DOI:10.3390/v15102066. PMID:37896843. IF:4,700 (Q2/5D). Document type: Article.
-Pinana JL, Martino R, Vazquez L, Lopez L, Perez A, Chorao P, Avendano A, Pascual MJ, Sanchez A, Sanz G, Olave MT, Arroyo I, Tormo M, Villalon L, Conesa V, Gago B, Terol MJ, Villalba M, Garcia V, Cabero A, Hernandez JA, Ferrer E, Garcia I, Teruel A, Navarro D, Cedillo A, Sureda A, Solano C. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. BONE MARROW TRANSPLANTATION. 2023; 58(5)DOI:10.1038/s41409-023-01946-0. PMID:36854892. IF:4,800 (Q1/2D). Document type: Article.
-Pinana JL, Perez A, Chorao P, Guerreiro M, Garcia I, Solano C, Martino R, Navarro D, Infect Complications Subcomm S. Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances. Transplant Infectious Disease. 2023; :e14117. DOI:10.1111/tid.14117. PMID:37585370. IF:2,600 (Q3/6D). Document type: Review.
-Pinana JL, Vazquez L, Calabuig M, Lopez L, Martin G, Villalon L, Sanz G, Conesa V, Sanchez A, Gago B, Facal A, Risco I, Olave MT, Espigado I, Lopez J, Hernandez JA, Avendano A, Arroyo I, Ferrer E, Garcia I, Gonzalez C, Roldan A, Ferrer B, Guerreiro M, Suarez M, Camara A, Campos D, Navarro D, Cedillo A, Sureda A, Solano C, Martino R, Spanish Hematopoietic Stem Cell TR. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Blood Cancer Journal. 2023; 13(1):8. DOI:10.1038/s41408-022-00778-3. PMID:36599843. IF:12,800 (Q1/1D). Document type: Article.
-Puertas B, González V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez J, Carrillo E, Clavero E, Ríos R, Rey B, González AP, Dourdil V, De Arriba F, González S, Pérez J, Hernández MT, García A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV. Randomized phase II study of weekly carfilzomib 70 mg/m(2) and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients. HAEMATOLOGICA. 2023; 108(10)DOI:10.3324/haematol.2022.282490. PMID:37102598. IF:10,100 (Q1/2D). Document type: Article.
-Rafii H, Ruggeri A, Kenzey C, Sanz J, Peffault de Latour R, Esquirol A, Michel G, Chevallier P, Rubio MT, Cornelissen JJ, Michallet M, Volt F, Rivera MM, Scigliuolo GM, Cappelli B, Rocha V, Gluckman E. Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe. Blood Advances. 2023; 7(10)DOI:10.1182/bloodadvances.2022007941. PMID:36350759. IF:7,500 (Q1/2D). Document type: Article.
-Rampotas A, Sockel K, Panitsas F, Theuser C, Bornhauser M, Hernani R, Hernandez JC, Esquirol A, Avenoso D, Tsirigotis P, Robin M, Czerw T, Helbig G, Roddie C, Lambert J, McLornan DP. Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study. Transplantation And Cellular Therapy. 2023; 29(11)DOI:10.1016/j.jtct.2023.08.020. PMID:37633414. IF:3,200 (Q2/5D). Document type: Article.
-Redondo S, De Dios A, Gomis M, Esquirol A, Aso O, Triquell M, Moreno ME, Riba M, Ruiz J, Blasco A, Tobajas E, Gonzalez I, Sierra J, Martino R, Garcia I. Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study. Transplantation And Cellular Therapy. 2023; 29(6):385.e1-385.e8. DOI:10.1016/j.jtct.2023.03.016. PMID:36948273. IF:3,200 (Q2/5D). Document type: Article.
-Redondo S, Garcia I, Vila A, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Arguello M, Onate G, Lopez J, Caballero AC, Miqueleiz S, Briones J, Sierra J, Sancho G, Martino R. Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI. EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; 111(1)DOI:10.1111/ejh.13978. PMID:37058419. IF:3,100 (Q3/6D). Document type: Article.
-Regalado I, Garcia M, Medina L, Fernandez J, Esquirol A, Garcia I, Martino R, Briones J, Sierra J, Novelli S. Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation. VOX SANGUINIS. 2023; 118(8)DOI:10.1111/vox.13486. PMID:37356813. IF:2,700 (Q3/7D). Document type: Article.
-Sierra J, Montesinos P, Thomas X, Griskevicius L, Cluzeau T, Caillot D, Legrand O, Minotti C, Luppi M, Farkas F, Bengoudifa BR, Gilotti G, Hodzic S, Rambaldi A, Venditti A. Midostaurin plus daunorubicin or idarubicin for young and elderly adults with FLT3-mutated AML: a Phase 3b trial. Blood Advances. 2023; 7(21)DOI:10.1182/bloodadvances.2023009847. PMID:37581981. IF:7,500 (Q1/2D). Document type: Article.
-Socié G, Barba P, Barlev A, Sanz J, García I, Chevallier P, Fagioli F, Guzman N, Kumar D, Ljungman P, Pigneux A, Sadetsky N, Yáñez San Segundo L, Shadman M, Storek J, Thirumalai D, Xing B, Mohty M. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. BONE MARROW TRANSPLANTATION. 2023; DOI:10.1038/s41409-023-02127-9. PMID:37865719. IF:4,800 (Q1/2D). Document type: Article.
-Solano C, Castro P, Pérez A, López L, Barba P, Kwon M, Ortiz V, Sanz J, Caballero AC, Martínez J, Cedillo Á, Sureda A. Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: A survey-based study. BMJ Open. 2023; 13(7):e071371. DOI:10.1136/bmjopen-2022-071371. PMID:37491085. IF:2,900 (Q2/5D). Document type: Article.
-Velao SR, Cadenas IG, Cuesta MA, Sanchez I, Fernandez F, Roldan E, Torrent A, Viguria MC, Villar S, Bento L, Yanez L, Martino R, Pinana JL, Espanol Trasplante Hematopoyet GRP. Low rate of infectious enterocolitis in allogeneic stem cell transplant recipients with acute diarrhea: A prospective study by the GETH-TC. ACTA HAEMATOLOGICA. 2023; 146(2)DOI:10.1159/000528242. PMID:36446336. IF:2,400 (Q3/8D). Document type: Article.
-Woyach JA, Ghia P, Byrd JC, Ahn IE, Moreno C, O’Brien SM, Jones D, Cheung LWK, Chong E, Kwei K, Dean JP, James DF, Wiestner A. B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy. CLINICAL CANCER RESEARCH. 2023; 29(16)DOI:10.1158/1078-0432.CCR-22-3887. PMID:37314786. IF:11,500 (Q1/1D).Collet R, Olmedo G, Ruiz I, Martinez A, Rodriguez B, Bernal S, Kulisevsky J, Pagonabarraga J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8). DOI:10.1002/mdc3.13811. PMID:37635772. IF:4,000 (Q2/4D). Document type: Article.
(JIF 2022)